查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
小分子 API 市場規模、份額和趨勢分析報告：按類型（合成、生物）、應用（腫瘤、呼吸、CNS、內分泌）、製造商、地區、細分市場、預測 2022-2030
市場調查報告書
商品編碼
1114142

小分子 API 市場規模、份額和趨勢分析報告：按類型（合成、生物）、應用（腫瘤、呼吸、CNS、內分泌）、製造商、地區、細分市場、預測 2022-2030

Small Molecule API Market Size, Share & Trends Analysis Report By Type (Synthetic, Biotech), By Application (Oncology, Pulmonology, CNS, Endocrinology), By Manufacturer, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

小分子原料藥市場增長與趨勢

Grand View Research, Inc. 的一份新報告預測，到 2030 年，全球小分子 API 市場規模將達到 2825 億美元，在預測期內以 5.44% 的複合年增長率增長。我是這裡。

這背後的驅動力是全球對藥品不斷增長的需求以及基於小分子的新藥的高批准率。

進入市場的新藥數量不斷增加，為主要參與者創造了有利可圖的機會。例如，根據 2021 NCBI，FDA 接受的藥物中有 75% 是小分子藥物，腫瘤學是主要的治療領域。這些批准中超過 50% 來自需要 CDMO 支持以推動 CDMO 增長的產品商業化的中小企業。

由於COVID-19大流行，小分子原料藥的生產基地集中在亞洲，如印度和中國，供應鏈問題變得明顯。這導致重點關注為客戶建立端到端的集成供應鏈，增加政府對此的支持，並增加西方國家的設施數量。

為了滿足全球不斷增長的需求，併購交易頻繁出現。例如，2022 年 4 月，諾華賽和 PharmaZell 宣布戰略合併，為複雜的小分子和特殊藥物製造創建領先的技術驅動型 CDMO。

市場擴張和多元化已成為主要市場參與者維持其份額的關鍵策略。例如，2021 年 4 月，龍沙宣布計劃投資 2.186 億美元在瑞士建設小分子製造綜合體。預計該設施將允許連續和靈活地供應產品。

中國、印度和東南亞等新興市場提供了巨大的增長機會。此外，由於對藥品的需求增加，尤其是在中東和東南亞國家，“Halal API”等利基領域也有望獲得增長機會。合成小分子 API 領域在很大程度上是由響應行業不斷變化的需求的小型公司和 CDMO 的存在推動的。

小分子 API 市場報告亮點

2021 年，由於對大批量藥品生產的需求很高，合成 API 佔據了最大的市場份額

由於中小型企業依賴外包進行商業生產，合同製造佔據了最大的市場份額

隨著癌症治療越來越流行以及對活性藥物成分的需求不斷增加，預計腫瘤學將顯示出最高的應用增長率

由於主要參與者的存在以及政府為加強該地區的 API 製造能力而增加的支持，北美在 2021 年主導了市場。

內容

第 1 章小分子 API 市場：研究方法和範圍

  • 市場細分
    • 段範圍
    • 區域範圍
    • 估計/預測時間表
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • Gvr 內部數據庫
    • 輔助信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法估算國別市場
      • 方法 2：使用自上而下的方法估算各國市場
  • 全球市場：CAGR 計算
  • 區域市場：CAGR 計算
  • 輔助信息列表
  • 目的
  • 縮寫列表

第 2 章小分子 API 市場：執行摘要

  • 小分子 API 市場：市場展望
    • 市場概覽

第 3 章小分子 API 市場：行業展望

  • 市場系列展望
    • 母市場譜系預測
    • 相關/子公司市場展望
  • 繪製滲透率和增長前景
  • 市場動態
    • 市場驅動力
      • 醫藥行業高速增長
      • 增加新分子的研發和推出
      • 增加 API 生產外包
      • 不斷增長的老年人口
      • 慢性病患病率
    • 市場約束分析
      • 生物製品的出現
      • 高度依賴亞洲國家的生產
  • 按因素（政治和法律、經濟和技術）進行 SWOT 分析
  • 行業分析 - 搬運工
  • 報銷和監管方案
  • 重大交易和戰略聯盟
    • 推出新產品
    • 獲取
    • 擴展名
    • 合作夥伴關係
    • 營銷和推廣

第 4 章小分子 API 市場：競爭格局

  • 主要市場參與者的近期趨勢和影響分析
    • 安索夫矩陣
  • 公司分類
    • 創新者
      • 市場差異化因素
  • 供應商情況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
    • 2021 年主要參與者的市場份額分析
  • 上市公司
    • 競爭信息中心分析
  • 私人公司
    • 主要初創公司列表
  • 本地網絡地圖

第 5 章小分子 API 市場：類型業務分析

  • 小分子 API 市場：類型變異分析
  • 合成
  • 生物技術

第 6 章小分子 API 市場：產品業務分析

  • 小分子原料藥市場：廠商波動分析
  • 內部
  • 外包

第 7 章小分子原料藥市場：製造商業務分析

  • 小分子原料藥市場：廠商波動分析
  • 心髒病學
  • 腫瘤學
  • 中樞神經系統和神經病學
  • 骨科
  • 內分泌科
  • 呼吸內科
  • 腸胃科
  • 腎臟科
  • 眼科
  • 其他

第 8 章小分子 API 市場：區域業務分析

  • 2021 年和 2030 年按國家/地區分列的市場份額分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 意大利
      • 西班牙
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 澳大利亞
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中東和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

第 9 章小分子 API 市場：公司概況

  • 公司簡介
    • 艾伯維公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 百時美施貴寶公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 勃林格殷格翰國際有限公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Cipla Inc.
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 梯瓦製藥工業有限公司
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 雅寶公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Viatris Inc.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 奧羅賓多製藥
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 太陽藥業有限公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 雷迪博士實驗室有限公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-952-0

Small Molecule API Market Growth & Trends:

The global small molecule API market size is expected to reach USD 282.50 billion by 2030, expanding at a CAGR of 5.44% during the forecast period, according to a new report by Grand View Research, Inc. It is driven by an increase in demand for pharmaceuticals globally and a high rate of new small molecule-based drug approval.

The increasing number of new pharmaceuticals entering the market is creating a lucrative opportunity for key players. For instance, as per NCBI in 2021, 75% of the drugs accepted by the FDA were small molecules, with the dominant therapeutic area being oncology. Over 50% of these approvals were from small and mid-sized companies which require support from CDMOs for the commercialization of products that enhance the growth rate of CDMOs.

The COVID-19 pandemic has made supply-chain shortcomings in the small-molecule API business apparent, as most of the production facilities are located in Asian nations such as India and China. This has increased the focus of players on creating an end-to-end integrated supply chain for the clients and increased the number of facilities in western countries with heightened support from the government for doing the same.

Merger and acquisition activities are frequently being undertaken by the players to meet the soaring demands globally. For instance, in April 2022, Novasep and PharmaZell announced a strategic merger for the creation of a leading technologically-driven CDMO for complex small molecules and specialty API production.

Expansion and diversification are becoming key strategies used by key players in the market to maintain their market share. For instance, in April 2021, Lonza announced its investment plan of USD 218.6 million for the construction of a manufacturing complex for small molecules in Switzerland. The facility is expected to ensure continuity and flexibility of supply for the products.

Emerging markets such as China, India, and Southeast Asia represent significant opportunities for growth. Furthermore, niche areas such as "halal API" further present growth opportunities owing to the rise in the demand for drugs in the segment, majorly in Middle Eastern and Southeast Asian nations. The synthetic small molecule API segment is largely driven by the presence of small companies and CDMOs that cater to the changing requirements of the industry.

Small Molecule API Market Report Highlights:

  • In 2021, synthetic APIs held the largest market share attributable to the high demand for the production of pharmaceuticals that are required in high volume
  • The outsourced manufacturing segment held the largest market share owing to a dependency of small and mid-sized companies on outsourcing for commercial production
  • Oncology is projected to grow at the fastest rate in the application segment as the adoption of cancer treatments is rising, creating a strong demand for API
  • North America dominated the market in 2021 due to the presence of key players and rising support from the government for enhancing the API manufacturing capacity of the region

Table of Contents

Chapter 1 Small Molecule API Market: Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
      • 1.6.1.3 Approach 2: Country-Wise Market Estimation Using Top-Down Approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Regional Market: CAGR Calculation
  • 1.9 List of Secondary Sources
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:
  • 1.11 List of Abbreviations

Chapter 2 Small Molecule API Market: Executive Summary

  • 2.1 Small Molecule API Market: Market Outlook
    • 2.1.1 Market Summary

Chapter 3 Small Molecule API Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 High growth of the pharmaceutical industry
      • 3.3.1.2 Rising R&D and launch of novel molecules
      • 3.3.1.3 Increased outsourcing of API production
      • 3.3.1.4 Growing geriatric population
      • 3.3.1.5 Escalating prevalence of chronic diseases
    • 3.3.2 Market restraint Analysis
      • 3.3.2.1 Emergence of biologics
      • 3.3.2.2 High dependence on Asian nations for production
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4 Small Molecule API Market: Competitive Landscape

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 4.1.1 Ansoff matrix
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
    • 4.3.3 Key company market share analysis, 2021
  • 4.4 Public Companies
    • 4.4.1 Competitive dashboard analysis
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies
  • 4.6 Regional Network Map

Chapter 5 Small Molecule API Market: Type Business Analysis

  • 5.1 Small Molecule API Market: Type Movement Analysis
  • 5.2 Synthetic
    • 5.2.1 Synthetic market estimates and forecast, 2018 - 2030 (USD Billion)
  • 5.3 Biotech
    • 5.3.1 Biotech market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 6 Small Molecule API Market: Product Business Analysis

  • 6.1 Small Molecule API Market: Manufacturer Movement Analysis
  • 6.2 In-house
    • 6.2.1 In-house market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.3 Outsourced
    • 6.3.1 Outsourced market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 7 Small Molecule API Market: Manufacturer Business Analysis

  • 7.1 Small Molecule API Market: Manufacturer Movement Analysis
  • 7.2 Cardiology
    • 7.2.1 Cardiology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.3 Oncology
    • 7.3.1 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.4 CNS and Neurology
    • 7.4.1 CNS and Neurology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.5 Orthopedic
    • 7.5.1 Orthopedic market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.6 Endocrinology
    • 7.6.1 Endocrinology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.7 Pulmonology
    • 7.7.1 Pulmunology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.8 Gastroenterology
    • 7.8.1 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.9 Nephrology
    • 7.9.1 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.10 Opthalmology
    • 7.10.1 Opthalmology market estimates and forecast, 2018 - 2030 (USD Billion)
  • 7.11 Others
    • 7.11.1 Other market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 8 Small Molecule API Market: Regional Business Analysis

  • 8.1 Market Share Analysis by Country, 2021 & 2030
    • 8.1.1 North America
      • 8.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.1.2 U.S.
      • 8.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.1.3 Canada
      • 8.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
    • 8.1.2 Europe
      • 8.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.2.2 UK
      • 8.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.2.3 Germany
      • 8.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.2.4 France
      • 8.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.2.5 Italy
      • 8.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.2.6 Spain
      • 8.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
    • 8.1.3 Asia-Pacific
      • 8.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.3.2 Japan
      • 8.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.3.3 China
      • 8.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.3.4 India
      • 8.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.3.5 South Korea
      • 8.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.3.6 Australia
      • 8.1.3.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
    • 8.1.4 Latin America
      • 8.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.4.2 Brazil
      • 8.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.4.3 Mexico
      • 8.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.4.4 Argentina
      • 8.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
    • 8.1.5 Middle East and Africa
      • 8.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.5.2 South Africa
      • 8.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.5.3 Saudi Arabia
      • 8.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
      • 8.1.5.4 UAE
      • 8.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 9 Small Molecule API Market: Company Profiling

  • 10.1 Company Profiles
    • 10.1.1 AbbVie, Inc.
      • 10.1.1.1 Company Overview
      • 10.1.1.2 Financial Performance
      • 10.1.1.3 Product Benchmarking
      • 10.1.1.4 Strategic Initiatives
    • 10.1.2 Bristol-Myers Squibb Company
      • 10.1.2.1 Company Overview
      • 10.1.2.2 Financial Performance
      • 10.1.2.3 Product Benchmarking
      • 10.1.2.4 Strategic Initiatives
    • 10.1.3 Boehringer Ingelheim International GmbH
      • 10.1.3.1 Company Overview
      • 10.1.3.2 Financial Performance
      • 10.1.3.3 Product Benchmarking
      • 10.1.3.4 Strategic Initiatives
    • 10.1.4 Cipla Inc.
      • 10.1.4.1 Company Overview
      • 10.1.4.2 Financial Performance
      • 10.1.4.3 Product Benchmarking
      • 10.1.4.4 Strategic Initiatives
    • 10.1.5 Teva Pharmaceutical Industries Ltd.
      • 10.1.5.1 Company Overview
      • 10.1.5.2 Financial Performance
      • 10.1.5.3 Product Benchmarking
      • 10.1.5.4 Strategic Initiatives
    • 10.1.6 Albemarle Corporation
      • 10.1.6.1 Company Overview
      • 10.1.6.2 Financial Performance
      • 10.1.6.3 Product Benchmarking
      • 10.1.6.4 Strategic Initiatives
    • 10.1.7 Viatris Inc.
      • 10.1.7.1 Company Overview
      • 10.1.7.2 Financial Performance
      • 10.1.7.3 Product Benchmarking
      • 10.1.7.4 Strategic Initiatives
    • 10.1.8 Aurobindo Pharma
      • 10.1.8.1 Company Overview
      • 10.1.8.2 Financial Performance
      • 10.1.8.3 Product Benchmarking
      • 10.1.8.4 Strategic Initiatives
    • 10.1.9 Sun Pharmaceutical Industries Ltd
      • 10.1.9.1 Company Overview
      • 10.1.9.2 Financial Performance
      • 10.1.9.3 Product Benchmarking
      • 10.1.9.4 Strategic Initiatives
    • 10.1.10 Dr. Reddy's Laboratories Ltd.
      • 10.1.10.1 Company Overview
      • 10.1.10.2 Financial Performance
      • 10.1.10.3 Product Benchmarking
      • 10.1.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Incidence of Diseases
  • Table 4 Global Small Molecule API Market, By Region, 2018 - 2030 (USD Billion)
  • Table 5 Global Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 6 Global Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 7 Global Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 8 North America Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 9 North America Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 10 North America Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 11 North America Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 12 U.S. Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 13 U.S. Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 14 U.S. Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 15 Canada Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 16 Canada Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 17 Canada Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 18 Europe Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 19 Europe Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 20 Europe Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 21 Europe Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 22 Germany Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 23 Germany Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 24 Germany Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 25 UK Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 26 UK Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 27 UK Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 28 France Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 29 France Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 30 France Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 31 Italy Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 32 Italy Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 33 Italy Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 34 Spain Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 35 Spain Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 36 Spain Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 37 Russia Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 38 Russia Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 39 Russia Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 40 Asia Pacific Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 41 Asia Pacific Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 42 Asia Pacific Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 43 Asia Pacific Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 44 Japan Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 45 Japan Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 46 Japan Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 47 China Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 48 China Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 49 China Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 50 India Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 51 India Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 52 India Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 53 South Korea Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 54 South Korea Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 55 South Korea Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 56 Australia Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 57 Australia Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 58 Australia Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 59 Latin America Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 60 Latin America Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 61 Latin America Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 62 Latin America Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 63 Brazil Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 64 Brazil Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 65 Brazil Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 66 Mexico Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 67 Mexico Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 68 Mexico Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 69 Argentina Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 70 Argentina Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 71 Argentina Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 72 Middle East & Africa Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 73 Middle East & Africa Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 74 Middle East & Africa Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 75 Middle East & Africa Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 76 Saudi Arabia Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 77 Saudi Arabia Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 78 Saudi Arabia Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 79 South Africa Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 80 South Africa Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 81 South Africa Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 82 UAE Small Molecule API Market, By Type, 2018 - 2030 (USD Billion)
  • Table 83 UAE Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 84 UAE Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Small molecule API market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Small molecule API market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook, revenue, 2021, (USD Billion)
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Small molecule API market driver impact
  • Fig. 14 Small molecule API market restraint impact
  • Fig. 15 SWOT analysis, by a factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Small molecule API market - Unmet needs analysis
  • Fig. 19 Small molecule API market: Type outlook and key takeaways
  • Fig. 20 Small molecule API market: Type movement analysis & market share 2021 & 2030
  • Fig. 21 Synthetic market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Biotech market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Small molecule API market: manufacturer outlook and key takeaways
  • Fig. 24 Small molecule API market: manufacturer movement analysis & market share 2021 & 2030
  • Fig. 25 In-house market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 Outsourced market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Small molecule API market: application outlook and key takeaways
  • Fig. 28 Small molecule API market: application movement analysis & market share 2021 & 2030
  • Fig. 29 Cardiology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 CNS and neurology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Orthopedic market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Endocrinology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Pulmonology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 37 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 38 Other market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 39 Small molecule API: Regional outlook and key takeaways
  • Fig. 40 Regional outlook, 2021 & 2030
  • Fig. 41 North America
  • Fig. 42 North America market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 U.S.
  • Fig. 44 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 Canada
  • Fig. 46 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 47 Europe
  • Fig. 48 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 UK
  • Fig. 50 UK market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 51 Germany
  • Fig. 52 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 53 France
  • Fig. 54 France market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 Italy
  • Fig. 56 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 Spain
  • Fig. 58 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 59 Russia
  • Fig. 60 Russia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 Asia-Pacific
  • Fig. 62 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 63 Japan
  • Fig. 64 Japan market estimates and forecast, 2018 - 2030(USD Billion)
  • Fig. 65 China
  • Fig. 66 China market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 67 India
  • Fig. 68 India market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 69 South Korea
  • Fig. 70 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 71 Australia
  • Fig. 72 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 73 Latin America
  • Fig. 74 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 75 Brazil
  • Fig. 76 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 77 Mexico
  • Fig. 78 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 79 Argentina
  • Fig. 80 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 81 Middle East & Africa
  • Fig. 82 MEA market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 83 South Africa
  • Fig. 84 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 85 Saudi Arabia
  • Fig. 86 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 87 UAE
  • Fig. 88 UAE market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 89 Ansoff Matrix
  • Fig. 90 Market differentiators
  • Fig. 91 Key company market share analysis, 2021
  • Fig. 92 Company market position analysis
  • Fig. 93 Competitive dashboard analysis
  • Fig. 94 Regional network map